Reporting owner · CIK 0001537529

Monia Brett P

Visual SEC Form 4 history across 1 companies, 13 transactions and 8 filings.

CEOChief Executive OfficerIONIS PHARMACEUTICALS INC
Open-market mix
Latest filingSep 03, 2026, 12:22 AM
Filings8Form 4 records
Buying$00 purchases
Selling$5.3M4 sales
Net value−$5.3MBuys minus sells
Companies14 securities
Most recentAug 31, 2026other

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Jan 251Feb 25Jan 261Feb 26Aug 26

Net value flow

Buys minus sells

Jan 25
−$1.5M
Feb 25
−$1.2M
Jan 26
$0
Feb 26
−$2.5M
Aug 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$1.3M
Median P/S size$1.2M
Direct13
Indirect0
Aug 31, 2026other

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern3Derivative Transactionfiling-context5Direct Ownershipfiling-context12Large Holdings Increaseholdings5Large Holdings Reductionholdings1Large Salesize3Repeat Sellerpattern210b5-1 Detectedfiling-context2

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at IONIS PHARMACEUTICALS INC on Feb 06, 2026 valued at $2,524,820.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at IONIS PHARMACEUTICALS INC on Feb 06, 2026 valued at $2,524,820.

Review SEC filing

Associated companies

Visual map of known reporting history

IONSIONIS PHARMACEUTICALS INC13 transactions · latest Sep 03, 2026, 12:22 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
IONSMonia Brett P
CEO
other98$502kJ
Direct Ownership
0.0%09/0308/31
IONSMonia Brett P
CEO
sale10b5-129.4k-$252MS
Cluster Selling Direct Ownership Large Sale+1
−10.6%02/1002/06
IONSMonia Brett P
CEO
grant85.4k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/0601/02
IONSMonia Brett P
CEO
other437$1.23MJ
Direct Ownership
—03/04/202502/28/2025
IONSMonia Brett P
CEO
sale10b5-138.8k-$122MS
Cluster Selling Direct Ownership Large Sale+2
—02/06/202502/04/2025
IONSMonia Brett P
CEO
sale13.2k-$42.9MS
Direct Ownership Repeat Seller
—02/04/202501/31/2025
IONSMonia Brett P
CEO
grant25.3k$0A
Direct Ownership
—02/04/202501/30/2025
IONSMonia Brett P
CEO
exercise73.4k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
—01/18/202501/15/2025
IONSMonia Brett P
CEO
grant129k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/18/202501/15/2025
IONSMonia Brett P
CEO
grant169k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/18/202501/15/2025

Monia Brett P Insider Activity FAQ

SEC Form 4 context

Who is Monia Brett P?

Monia Brett P is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001537529.

Which companies has Monia Brett P reported transactions for?

IONIS PHARMACEUTICALS INC

When was Monia Brett P's latest insider buy?

No open-market insider purchase is available for this period.

When was Monia Brett P's latest insider sale?

sale at IONIS PHARMACEUTICALS INC on Feb 06, 2026 valued at $2,524,820.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.